Skip to main content

U.S. Venture Partners — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

222
Companies
$2.2B
Total invested
$27.7M
Avg. check
51
Industries
Software 11Artificial Intelligence (AI) 8SaaS 6Health Care 5Developer APIs 4Machine Learning 3+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 222
Iambic
September 2026

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI) · San Diego$66.0M Debt Financing
Lightsage
September 2026

Lightsage tracks how AI engines and coding agents find and use software APIs.

San Francisco$4.0M Seed
BuyBuddy
September 2024

BuyBuddy is an IoT technology company that offers curated solutions for boosting offline conversion through physical engagements.

Analytics · KadikoySeed
Sol
September 2026

Sol a company focused on building tools to power team collaboration and collective productivity.

DevOps · Dover$4.0M Seed
Firecrawl
September 2026

Firecrawl provides web data infrastructure that enables AI systems and developers to search, scrape, map, and interact with web pages.

Artificial Intelligence (AI) · San Francisco$75.0M Series B
Tile.ai
September 2026

Tile.ai is an AI data infrastructure company that helps life sciences, healthcare, defense, financial industries.

Analytics · Cambridge$34.0M Venture - Series Unknown
Highlight Therapeutics
September 2025

Highlight Therapeutics is a clinical-stage biopharmaceutical company.

Biopharma · Paterna$17.8M Venture - Series Unknown
EmbodyX
September 2025

EmbodyX builds Physical AI that powers the industrial world

San Mateo$2.0M Pre-Seed
Naive
August 2026

Naïve provides infrastructure and AI agents for building and operating applications, businesses, and automated workflows.

Agentic AI · San Francisco$28.5M Series A
Artax Biopharma
August 2024

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

Biopharma · Cambridge$8.0M Convertible Note
Cricket Health
August 2021

Cricket Health is a specialty kidney care provider of integrated nephrology and dialysis care.

Health Care · San Francisco$83.5M Series B
Apollo.io
August 2023

Building the industry’s first fully agentic GTM platform, transforming how revenue teams execute

Artificial Intelligence (AI) · San FranciscoSeries D
Postman
August 2021

Postman is a software company that offers a platform for the users to design, develop, test, and organize custom APIs.

Developer APIs · San Francisco$225.0M Series D
HyperTrack
August 2022

Location API for business automation

Developer APIs · San Francisco$25.0M Series A
Phyllo
August 2022

Universal APIs for social data & insights

Analytics · San Francisco$15.0M Series A
Dynamo AI
August 2023

The enterprise platform for enabling private, secure, and regulation-compliant Gen AI models.

Artificial Intelligence (AI) · San FranciscoSeries A
Traydstream
August 2026

Traydstream automates the most critical aspects of converting, checking and managing trade finance documents.

Artificial Intelligence (AI) · London$11.0M Venture - Series Unknown
Clean Crop Technologies
July 2026

Clean Crop Technologies specializes in advanced treatments for foods and seeds, effectively reducing mold, pathogens, and bacteria.

AgTech · Holyoke$7.9M Venture - Series Unknown
Rocketlane
July 2026

Rocketlane is a PSA platform that provides project management and collaboration services.

Collaboration · Wilmington$60.0M Venture - Series Unknown
NeRRe Therapeutics
July 2021

NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.

Biotechnology · Stevenage$27.6M Series B
Olto
July 2025

Olto crafts personalized live demos by overlaying AI-generated, prospect-relevant data on top of your existing production apps.

Artificial Intelligence (AI) · San Francisco$5.1M Pre-Seed
Wootz.work
February 2026

Wootz.work uses technology and ownership of the process from design to delivery to improve the purchasing experience for engineering items.

Developer Platform · New Delhi$6.6M Series A
Neysa
February 2026

Neysa is an AI acceleration platform that develops AI native applications for businesses.

AI Infrastructure · Mumbai$600.0M Series Unknown
AssetPlus
January 2026

AssetPlus is a digital wealth-tech platform that manages client portfolios and financial products through a unified system.

Finance · Chennai$19.3M Series B

Where U.S. Venture Partners invests

Software11
Artificial Intelligence (AI)8
SaaS6
Health Care5
Developer APIs4
Machine Learning3

About U.S. Venture Partners's portfolio

How many companies has U.S. Venture Partners invested in?▸

U.S. Venture Partners has invested in 222 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does U.S. Venture Partners invest in?▸

U.S. Venture Partners's top investment sectors include Software, Artificial Intelligence (AI), SaaS, Health Care, Developer APIs. The firm invests across 51 different industry categories.

What is U.S. Venture Partners's largest investment?▸

Among tracked funding rounds, Neysa received $600.0M in a Series Unknown round. U.S. Venture Partners's total known invested capital is $2.2B.

What is the average investment size for U.S. Venture Partners?▸

U.S. Venture Partners's average investment size is $27.7M across its portfolio of 222 companies.

What are U.S. Venture Partners's most recent investments?▸

Recent U.S. Venture Partners portfolio additions include Iambic, Lightsage, BuyBuddy, Sol, Firecrawl. These companies were founded in 2020 or later.

Reach the founders behind these 222 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →